Table 1.
Differences in baseline characteristics between MAC and GA
|
Study |
Yamamoto |
Motloch |
Dhedin |
Ben-Dor |
Behan |
Linke |
Covello |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | GA | MAC | GA | MAC | GA | MAC | GA | MAC | GA | MAC | GA | MAC | GA | |
| n |
130 |
44 |
41 |
33 |
34 |
91 |
42 |
27 |
9 |
3 |
547 |
449 |
42 |
27 |
| Logistic EuroScore |
22.0* |
26.6* |
NA |
NA |
23.6 |
24 |
40.1* |
28.1* |
21.8 |
22.9 |
** |
** |
27.3 |
22.9 |
| STS score (mortality) |
11.2 |
14.3 |
20.8 |
16.5 |
9.2* |
14* |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
| Prior CVA/TIA |
10.1% |
11.1% |
14.6% |
24.2% |
12% |
11% |
30%* |
9.1%* |
11% |
33% |
NA |
NA |
19% |
15% |
| CAD |
10.1% |
11.1% |
43.9% |
42.4% |
44% |
52% |
55.7% |
45.5% |
NA |
NA |
** |
** |
57% |
44% |
| Renal dysfunction (CrCl >60 ml/minute) |
68.5% |
63.6% |
NA |
NA |
56% |
44% |
37.1% |
50% |
11% |
0% |
NA |
NA |
NA |
NA |
| Age |
83.7 |
84.7 |
82.6 |
83.4 |
83.5 |
83 |
84.1 |
83.7 |
80 |
83 |
** |
** |
79.5 |
77.6 |
| Females |
60.5% |
53.3% |
65.9% |
45.5% |
47% |
50% |
58.5% |
63.6% |
33% |
33% |
** |
** |
NA |
NA |
| Diabetes |
25.6% |
13.3% |
29.3% |
27.3% |
23% |
19% |
30% |
31.8% |
NA |
NA |
** |
** |
33% |
30% |
| Hypertension |
81.4% |
73.3% |
82.5% |
75.8% |
74% |
64% |
90% |
95.5% |
NA |
NA |
NA |
NA |
NA |
NA |
| COPD |
23.3% |
24.4% |
9.8% |
12.1% |
15% |
30% |
14.3% |
9.1% |
33% |
33% |
NA |
NA |
69% |
37% |
| EF |
50.4%* |
45.1%* |
53.6% |
54.8% |
57% |
50% |
52.7% |
55.2% |
NA |
NA |
NA |
NA |
NA |
NA |
| AVA (cm2) | 0.67 | 0.72 | 0.6 | 0.6 | 0.42 | 0.38 | 0.63 | 0.65 | NA | NA | NA | NA | NA | NA |
A, not available; AVA aortic valve area, CAD coronary artery disease, COPD, chronic obstructive pulmonary disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; EF ejection fraction, GA, general anesthesia; MAC, monitored anesthesia care; STS, Society of Thoracic Surgeons score; *significant. **No statistically significant difference according to authors, numbers not available.